Michael Kaswan - Net Worth and Insider Trading

Michael Kaswan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Kaswan owns 3 companies in total, including Summer Infant Inc (SUMR) , Health Sciences Acquisitions Corp 2 (HSAQ) , and Orchestra BioMed Holdings Inc (OBIO) .

Click here to see the complete history of Michael Kaswan’s form 4 insider trades.

Insider Ownership Summary of Michael Kaswan

Ticker	Comapny	Transaction Date	Type of Owner
SUMR	Summer Infant Inc	2005-04-21	director & 10 percent owner & Chief Operating Officer
HSAQ	Health Sciences Acquisitions Corp 2	2023-01-26	Chief Financial Officer
OBIO	Orchestra BioMed Holdings Inc	2023-01-26	Chief Financial Officer

Michael Kaswan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael Kaswan Ownership Network

Ownership Network List of Michael Kaswan

No Data

Ownership Network Relation of Michael Kaswan

Michael Kaswan Owned Company Details

What does Summer Infant Inc do?

Who are the key executives at Summer Infant Inc?

Michael Kaswan is the director & 10 percent owner & Chief Operating Officer of Summer Infant Inc. Other key executives at Summer Infant Inc include 10 percent owner Jason P Macari , Interim CFO Bruce Meier , and 10 percent owner Wynnefield Partners Small Cap Value Lp .

Summer Infant Inc (SUMR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Summer Infant Inc (SUMR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Summer Infant Inc (SUMR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Summer Infant Inc (SUMR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Summer Infant Inc Insider Transactions

No Available Data

What does Health Sciences Acquisitions Corp 2 do?

Who are the key executives at Health Sciences Acquisitions Corp 2?

Michael Kaswan is the Chief Financial Officer of Health Sciences Acquisitions Corp 2. Other key executives at Health Sciences Acquisitions Corp 2 include director & See Remarks David P Hochman , director & See Remarks Darren Sherman , and 10 percent owner Plc Medtronic .

Health Sciences Acquisitions Corp 2 (HSAQ) Insider Trades Summary

Over the past 18 months, Michael Kaswan made no insider transaction in Health Sciences Acquisitions Corp 2 (HSAQ). Other recent insider transactions involving Health Sciences Acquisitions Corp 2 (HSAQ) include a net purchase of 1,808,512 shares made by Roderick Wong ,

In summary, during the past 3 months, insiders sold 0 shares of Health Sciences Acquisitions Corp 2 (HSAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Health Sciences Acquisitions Corp 2 (HSAQ) were sold and 1,808,512 shares were bought by its insiders, resulting in a net purchase of 1,808,512 shares.

Health Sciences Acquisitions Corp 2 (HSAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Health Sciences Acquisitions Corp 2 Insider Transactions

No Available Data

What does Orchestra BioMed Holdings Inc do?

Who are the key executives at Orchestra BioMed Holdings Inc?

Michael Kaswan is the Chief Financial Officer of Orchestra BioMed Holdings Inc. Other key executives at Orchestra BioMed Holdings Inc include See Remarks George Papandreou , director & See Remarks David P Hochman , and director & See Remarks Darren Sherman .

Orchestra BioMed Holdings Inc (OBIO) Insider Trades Summary

Over the past 18 months, Michael Kaswan made no insider transaction in Orchestra BioMed Holdings Inc (OBIO). Other recent insider transactions involving Orchestra BioMed Holdings Inc (OBIO) include a net purchase of 6,835 shares made by Plc Medtronic ,

In summary, during the past 3 months, insiders sold 0 shares of Orchestra BioMed Holdings Inc (OBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Orchestra BioMed Holdings Inc (OBIO) were sold and 6,835 shares were bought by its insiders, resulting in a net purchase of 6,835 shares.

Orchestra BioMed Holdings Inc (OBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Orchestra BioMed Holdings Inc Insider Transactions

No Available Data

Michael Kaswan Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Kaswan. You might contact Michael Kaswan via mailing address: Kbl Healthcare Acquisition Corp Ii, 645 Madison Avenue, New York Ny 10022.

Discussions on Michael Kaswan

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.